Here’s what you should know.
1. The grant will help the drugmaker continuing refining the aspirin.
2. Lenard M. Lichtenberger, PhD, of Houston-based University of Texas Health Science Center, will serve as principal investigator.
3. The principle study will examine the aspirin’s role in colorectal cancer prevention.
4. The grant will come in two annual installments in 2017 and 2018.
More articles on gastroenterology:
Underwater colonoscopy more effective than air insufflation — 5 insights
Drs. David Ahlquist & Anil Rustgi: 8 GI physicians in the headlines
GI leader to know: Dr. Dino Ferrante of the Center for Colon & Digestive Disease
